Table 5.

Statin prescribing in patients eligible for treatment after the Health Check; multivariable analysis

		High risk patients
		Pre-Health Check		Post-Health Check
		%	AOR	%	AOR
Sex	Malea	16.8	1.00	54.3	1.00
	Female	21.6*	1.11 (0.71–1.72)	47.2*	0.75 (0.53–1.06)
Age group	40–54a	9.83	1.00	49.2	1.00
	55–64	17.4**	1.87 (1.02–3.40)	51.9	1.08 (0.73–1.59)
	65–74	21.4**	2.49 (1.33–4.67)	55.6	1.30 (0.86–1.98)
Ethnicity	Whitea	17.8	1.00	51.9	1.00
	Black	14.2	0.75 (0.33–1.70)	60.4	2.11 (1.12–3.95)
	South Asian	25.0	0.92 (0.40–2.13)	55.4	0.89 (0.49–1.60)
	Other	16.8	0.83 (0.45–1.54)	54.2	0.98 (0.64–1.50)
	Missingb	7.14	0.50 (0.06–4.26)	53.6	1.16 (0.40–3.40)
Local deprivation thirdc	1a	18.6	1.00	55.4	1.00
	2	16.1	1.15 (0.74–1.80)	52.6	1.03 (0.75–1.42)
	3	18.4	1.41 (0.89–2.21)	50.8	0.96 (0.69–1.34)
Non-CVD co-morbiditiesd	Noa	16.2	1.00	53.2	1.00
	Yes	21.1*	2.06 (1.43–2.96)	52.3	1.34 (1.01–1.78)
Family history of CHD	Noa	16.8	1.00	52.8	1.00
	Yes	19.0	1.20 (0.84–1.72)	53.1	0.89 (0.68–1.16)
Smoking Status	Noa	19.0	1.00	50.1	1.00
	Yes	16.3	0.99 (0.68–1.43)	55.8*	1.41 (1.07–1.87)
Practice list size	<6000a	21.0	1.00	58.3	1.00
	6000–10 000	17.3	0.67 (0.30–1.49)	48.0**	0.72 (0.44–1.19)
	>10 000	14.5**	0.58 (0.23–1.46)	52.1*	0.92 (0.53–1.61)
Total		17.7		52.9
Random effects
Median odds ratio			2.34 (1.98–2.91)		1.89 (1.63–2.30)
Variance partitioning coefficient			18.8 (13.0–26.7)		11.6 (7.06–18.2)

Note: Odds ratios are adjusted for all variables in the table.

^aReference group in z-test, **P < 0.01 and *P < 0.05 for z-test.

^bPatients with either no ethnicity recording or patients who did not want to state their ethnicity.

^cIndex of Multiple Deprivation 2007 (1 = most deprived, 3 = least deprived).

^dNon-CVD co-morbidities – asthma, mental health, depression, hypothyroidism and chronic obstructive pulmonary disease.